$34.03 -2.3 -6.2%
Last Trade - 3:56pm
| Market Cap | ÂŁ854.8m |
| Enterprise Value | ÂŁ787.2m |
| Revenue | ÂŁ30.0m |
| Position in Universe | 2622nd / 6647 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 6.19 | 6.45 | 8.23 | 11.0 | 19.7 | 27.4 | 46.9 | 69.5 | +34.6% | ||
| -52.6 | ||||||||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
BioLife Solutions, Inc. (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers. The Company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; custom product formulation and custom packaging services; cold chain logistics services incorporating precision thermal packaging products and cloud-hosted Web applications, and contract aseptic manufacturing formulation, fill and finish services of liquid media products. Its products include HypoThermosol FRS, CryoStor, BloodStor, Cell Thawing Media, PrepaStor and biologistex cold-chain management service.
| Last Annual | December 31st, 2019 |
| Last Interim | September 30th, 2020 |
| Incorporated | March 25, 1998 |
| Public Since | November 8, 2007 |
| No. of Shareholders: | 161 |
| No. of Employees: | 151 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | Nasdaq Composite , |
| Exchange | NASDAQ Capital Market |
| Shares in Issue | 32,735,912 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 3303 Monte Villa Pkwy Ste 310, BOTHELL, 98021-6200, United States |
| Web | https://biolifesolutions.com/ |
| Phone | +1 425 4011400 |
| Contact | Roderick de Greef (Chief Financial Officer, Chief Operating Officer, Secretary, IR Contact Officer) |
| Auditors | Peterson Sullivan LLP |
As of 3:56pm, shares in BioLife Solutions Inc are trading at $34.03, giving the company a market capitalisation of ÂŁ854.8m. This share price information is delayed by 15 minutes.
Shares in BioLife Solutions Inc are currently trading at $34.03 and the price has moved by 0.153k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the BioLife Solutions Inc price has moved by 0.100k% over the past year.
Of the analysts with advisory recommendations for BioLife Solutions Inc, there are there are currently 1 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for BioLife Solutions Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.
BioLife Solutions Inc is scheduled to issue upcoming financial results on the following dates:
BioLife Solutions Inc does not currently pay a dividend.
BioLife Solutions Inc does not currently pay a dividend.
BioLife Solutions Inc does not currently pay a dividend.
To buy shares in BioLife Solutions Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in BioLife Solutions Inc are currently trading at $34.03, giving the company a market capitalisation of ÂŁ854.8m.
Here are the trading details for BioLife Solutions Inc:
Based on an overall assessment of its quality, value and momentum, BioLife Solutions Inc is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in BioLife Solutions Inc are currently priced at $34.03. At that level they are trading at 21.86% discount to the analyst consensus target price of 0.00.
Analysts covering BioLife Solutions Inc currently have a consensus Earnings Per Share (EPS) forecast of 0.19 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like BioLife Solutions Inc. Over the past six months, the relative strength of its shares against the market has been 43.07%. At the current price of $34.03, shares in BioLife Solutions Inc are trading at 26.06% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for BioLife Solutions Inc.
BioLife Solutions Inc's management team is headed by:
Here are the top five shareholders of BioLife Solutions Inc based on the size of their shareholding:
